Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials

Marya Viorst Gwadz, Pablo Colon, Amanda S. Ritchie, Noelle R. Leonard, Charles M. Cleland, Marion Riedel, Deshannon Bowens, Angela D. Banfield, Patricia Chang, Robert Quiles, Donna Mildvan

Research output: Contribution to journalArticle

Abstract

Persons living with HIV/AIDS (PLHA) of color are under-represented in AIDS clinical trials (ACTs), which may limit the generalizability of research findings and denies many individuals access to high levels of care and new treatments available through ACTs. Disproportionately low rates of recruitment in health care settings and by providers are a major barrier to ACTs for this group. Moreover, PLHA of color are more likely than their white peers to decline to participate, mainly due to fear and mistrust (although willingness is also high), negative social norms about ACTs, and difficulty navigating the unfamiliar ACT system. We describe a small number of successful behavioral and structural interventions to increase the participation of PLHA of color in screening for and enrollment into ACTs. HIV care settings, clinical trials sites, and trial sponsors are uniquely positioned to develop procedures, supports, and trials to increase the proportion of PLHA of color in ACTs.

Original languageEnglish (US)
Pages (from-to)194-200
Number of pages7
JournalCurrent HIV/AIDS Reports
Volume7
Issue number4
DOIs
StatePublished - Nov 2010

Fingerprint

Acquired Immunodeficiency Syndrome
Color
Clinical Trials
HIV
Health Personnel
Fear
Research

Keywords

  • Access
  • African-American
  • Clinical trials
  • HIV/AIDS
  • Latino
  • Racial/ethnic disparities

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials. / Gwadz, Marya Viorst; Colon, Pablo; Ritchie, Amanda S.; Leonard, Noelle R.; Cleland, Charles M.; Riedel, Marion; Bowens, Deshannon; Banfield, Angela D.; Chang, Patricia; Quiles, Robert; Mildvan, Donna.

In: Current HIV/AIDS Reports, Vol. 7, No. 4, 11.2010, p. 194-200.

Research output: Contribution to journalArticle

Gwadz, MV, Colon, P, Ritchie, AS, Leonard, NR, Cleland, CM, Riedel, M, Bowens, D, Banfield, AD, Chang, P, Quiles, R & Mildvan, D 2010, 'Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials', Current HIV/AIDS Reports, vol. 7, no. 4, pp. 194-200. https://doi.org/10.1007/s11904-010-0055-3
Gwadz, Marya Viorst ; Colon, Pablo ; Ritchie, Amanda S. ; Leonard, Noelle R. ; Cleland, Charles M. ; Riedel, Marion ; Bowens, Deshannon ; Banfield, Angela D. ; Chang, Patricia ; Quiles, Robert ; Mildvan, Donna. / Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials. In: Current HIV/AIDS Reports. 2010 ; Vol. 7, No. 4. pp. 194-200.
@article{cf038865a9624748973863c7538e8cf6,
title = "Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials",
abstract = "Persons living with HIV/AIDS (PLHA) of color are under-represented in AIDS clinical trials (ACTs), which may limit the generalizability of research findings and denies many individuals access to high levels of care and new treatments available through ACTs. Disproportionately low rates of recruitment in health care settings and by providers are a major barrier to ACTs for this group. Moreover, PLHA of color are more likely than their white peers to decline to participate, mainly due to fear and mistrust (although willingness is also high), negative social norms about ACTs, and difficulty navigating the unfamiliar ACT system. We describe a small number of successful behavioral and structural interventions to increase the participation of PLHA of color in screening for and enrollment into ACTs. HIV care settings, clinical trials sites, and trial sponsors are uniquely positioned to develop procedures, supports, and trials to increase the proportion of PLHA of color in ACTs.",
keywords = "Access, African-American, Clinical trials, HIV/AIDS, Latino, Racial/ethnic disparities",
author = "Gwadz, {Marya Viorst} and Pablo Colon and Ritchie, {Amanda S.} and Leonard, {Noelle R.} and Cleland, {Charles M.} and Marion Riedel and Deshannon Bowens and Banfield, {Angela D.} and Patricia Chang and Robert Quiles and Donna Mildvan",
year = "2010",
month = "11",
doi = "10.1007/s11904-010-0055-3",
language = "English (US)",
volume = "7",
pages = "194--200",
journal = "Current HIV/AIDS Reports",
issn = "1548-3568",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials

AU - Gwadz, Marya Viorst

AU - Colon, Pablo

AU - Ritchie, Amanda S.

AU - Leonard, Noelle R.

AU - Cleland, Charles M.

AU - Riedel, Marion

AU - Bowens, Deshannon

AU - Banfield, Angela D.

AU - Chang, Patricia

AU - Quiles, Robert

AU - Mildvan, Donna

PY - 2010/11

Y1 - 2010/11

N2 - Persons living with HIV/AIDS (PLHA) of color are under-represented in AIDS clinical trials (ACTs), which may limit the generalizability of research findings and denies many individuals access to high levels of care and new treatments available through ACTs. Disproportionately low rates of recruitment in health care settings and by providers are a major barrier to ACTs for this group. Moreover, PLHA of color are more likely than their white peers to decline to participate, mainly due to fear and mistrust (although willingness is also high), negative social norms about ACTs, and difficulty navigating the unfamiliar ACT system. We describe a small number of successful behavioral and structural interventions to increase the participation of PLHA of color in screening for and enrollment into ACTs. HIV care settings, clinical trials sites, and trial sponsors are uniquely positioned to develop procedures, supports, and trials to increase the proportion of PLHA of color in ACTs.

AB - Persons living with HIV/AIDS (PLHA) of color are under-represented in AIDS clinical trials (ACTs), which may limit the generalizability of research findings and denies many individuals access to high levels of care and new treatments available through ACTs. Disproportionately low rates of recruitment in health care settings and by providers are a major barrier to ACTs for this group. Moreover, PLHA of color are more likely than their white peers to decline to participate, mainly due to fear and mistrust (although willingness is also high), negative social norms about ACTs, and difficulty navigating the unfamiliar ACT system. We describe a small number of successful behavioral and structural interventions to increase the participation of PLHA of color in screening for and enrollment into ACTs. HIV care settings, clinical trials sites, and trial sponsors are uniquely positioned to develop procedures, supports, and trials to increase the proportion of PLHA of color in ACTs.

KW - Access

KW - African-American

KW - Clinical trials

KW - HIV/AIDS

KW - Latino

KW - Racial/ethnic disparities

UR - http://www.scopus.com/inward/record.url?scp=77958085254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958085254&partnerID=8YFLogxK

U2 - 10.1007/s11904-010-0055-3

DO - 10.1007/s11904-010-0055-3

M3 - Article

C2 - 20737252

AN - SCOPUS:77958085254

VL - 7

SP - 194

EP - 200

JO - Current HIV/AIDS Reports

JF - Current HIV/AIDS Reports

SN - 1548-3568

IS - 4

ER -